![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » ChondroGene Receives Funding Support From NRC-IRAP
ChondroGene Receives Funding Support From NRC-IRAP
March 16, 2005
ChondroGene reported that it has received a contribution from National Research Council's Industrial Research Assistance Program (NRC-IRAP) in support of the development of a blood-based molecular diagnostic assay that will be able to detect early, asymptomatic osteoarthritis as well as stage the severity of the disease. ChondroGene will use its proprietary approach, the Sentinel Principle, to identify blood-based biomarkers that are associated with osteoarthritis. Once validated, these biomarkers will form the basis of a diagnostic test.
Canada NewsWire (http://www.newswire.ca/en/releases/archive/March2005/16/c5155.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct